Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 349,563 | 278,288 | N/A | N/A |
| Depreciation Amortization | 168,116 | 55,775 | N/A | N/A |
| Income taxes - deferred | 43,484 | -11,892 | N/A | N/A |
| Other Working Capital | -176,263 | -28,829 | N/A | N/A |
| Other Operating Activity | -423 | -52,751 | 0 | 0 |
| Operating Cash Flow | $384,477 | $240,591 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -3,915 | -4,292 | N/A | N/A |
| Net Acquisitions | -1,362,704 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -81 | N/A | N/A |
| Purchase Sale Intangibles | -927,654 | -61,851 | N/A | N/A |
| Other Investing Activity | -927,654 | -61,871 | 0 | 0 |
| Investing Cash Flow | $-2,294,273 | $-66,244 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,679,575 | N/A | N/A | N/A |
| Debt Repayment | N/A | -236 | N/A | N/A |
| Other Financing Activity | -10,051 | 0 | 0 | 0 |
| Financing Cash Flow | $1,669,524 | $-236 | $N/A | $N/A |
| Exchange Rate Effect | 952 | 849 | N/A | N/A |
| Beginning Cash Position | 317,294 | 170,175 | N/A | N/A |
| End Cash Position | 77,975 | 345,155 | N/A | N/A |
| Net Cash Flow | $-239,320 | $174,980 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 384,477 | 240,591 | N/A | N/A |
| Capital Expenditure | -3,915 | -4,663 | N/A | N/A |
| Free Cash Flow | 380,563 | 235,928 | 0 | 0 |